MoneyWorks4Me

Gland Pharma - Quaterly Results

04 Nov 2025 Evaluate
The total revenue for the quarter ended September 2025 remained nearly unchanged at Rs. 10741.52 millions.A slim rise of 7.20% was recorded in the Net profit for the quarter ended September 2025 to Rs. 3019.95  millions  From Rs. 2817.10 millions.Operating profit surged to 4574.79 millions from the corresponding previous quarter of 4216.03 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202509 202409 % Var 202509 202409 % Var 202503 202403 % Var
Sales 10741.52 10629.90 1.05 21129.87 20750.14 1.83 41161.49 41674.28 -1.23
Other Income 825.92 578.03 42.89 1373.33 1062.93 29.20 2150.75 1666.66 29.05
PBIDT 4574.79 4216.03 8.51 8710.65 7636.46 14.07 16576.93 15754.47 5.22
Interest 39.71 1.72 2208.72 114.06 10.83 953.19 228.37 78.43 191.18
PBDT 4535.08 4214.31 7.61 8596.59 7625.63 12.73 16348.56 15676.04 4.29
Depreciation 448.35 416.15 7.74 886.03 824.32 7.49 1692.71 1621.07 4.42
PBT 4086.73 3798.16 7.60 7710.56 6801.31 13.37 14655.85 14054.97 4.28
TAX 1066.78 981.06 8.74 1998.03 1755.00 13.85 3758.32 3621.72 3.77
Deferred Tax 7.80 17.74 -56.03 6.34 29.56 -78.55 91.24 246.84 -63.04
PAT 3019.95 2817.10 7.20 5712.53 5046.31 13.20 10897.53 10433.25 4.45
Equity 164.76 164.75 0.01 164.76 164.75 0.01 164.76 164.71 0.03
PBIDTM(%) 42.59 39.66 7.38 41.22 36.80 12.02 40.27 37.80 6.53
Peers
Company Name CMP
Sun Pharma. Inds. 1868.00
Dr. Reddys Labs. 1202.00
Cipla 1385.00
Lupin 2120.00
Zydus Lifesciences 1161.50
View more..